Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.545 USD | +3.65% | +5.74% | +110.84% |
May. 30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- Official Publications